Fairvalue-Calculator Fairvalue-Calculator
EN DE

DSFIR (DSFIR) Fair Value & Analysis

Basic Materials · Market cap CHF 19.0B

D DSFIR DSFIR · SW
PriceCHF 76.70
Fair ValueCHF 30.16
Upside-60.7%
Quality90/100
Evidence: Medium Range CHF 19.56 – CHF 40.77

Fair value as of: Jul 1, 2026

From 14 valuation models · updated today

Share price +16.1% over the past month.

Price vs Fair Value (1 month)

CHF 76.70 CHF 60.37 Fair Value CHF 30.16 May 2026 Jun 2026

1‑month range CHF 60.37 – CHF 76.70 · fair‑value band CHF 19.56 – CHF 40.77 · the CHF 76.70 price screens above the CHF 30.16 fair value. As of Jul 1, 2026.

✦ Find undervalued quality stocks — 35,000+ analysed Find stocks →

Analysis

DSFIR (DSFIR) currently trades at CHF 76.70, while our model-based Fair Value estimate is CHF 30.16 — implying the stock looks roughly 60.7% overvalued today. We read business quality at 90/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, DSFIR generated revenue of CHF 9.0B at a net margin of -12.0%. It earns a return on equity of 1.7%. Net debt stands at CHF 3.0B. The stock trades on a trailing P/E of 59.5. Fundamentals as of Jul 1, 2026

Key figures & financial health

Revenue (TTM) CHF 9.0B
Net margin -12.0%
Return on equity 1.7%
Free cash flow CHF 651M FY2025
P/E ratio 59.5
Operating margin 7.0%
More key figures
EPS (TTM) CHF 1.11
Net debt CHF 3.0B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 1, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2025 · reported fiscal years

DSFIR reported revenue of CHF 9.0B in FY2025 versus CHF 8.4B in FY2022, a compound +2.5%/yr. Reported net income was −CHF 1.1B in FY2025.

Revenue +2.5%/yr
FY22 CHF 8.4B
FY23 CHF 10.6B
FY24 CHF 9.1B
FY25 CHF 9.0B
Net income
FY22 CHF 1.7B
FY23 CHF 2.1B
FY24 CHF 250M
FY25 −CHF 1.1B

Open the full interactive analysis →

Similar stocks

6 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 1, 2026).

Stock Price Fair Value vs Fair Value
Linde plc LIN $516.71 $221.55 -57%
L'Air Liquide S.A AIQUY $37.81 $15.56 -59%
Air Products and Chemicals, Inc A1PD34 R$360.05 R$174.71 -51%
Intercontinental Exchange, Inc I1CE34 R$359.64 R$307.76 -14%
Wanhua Chemical Group 600309 ¥67.90 ¥46.52 -31%
Asian Paints Limited ASIANPAINT ₹2,687 ₹655.71 -76%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is DSFIR (DSFIR) undervalued?
As of Jul 1, 2026, our model estimates a fair value of CHF 30.16 versus a price of CHF 76.70 — about −61% (overvalued). Model-based estimate, not financial advice.
What is the fair value of DSFIR?
Our 21-model fair value for DSFIR is CHF 30.16 (as of Jul 1, 2026), built from audited fundamentals. The current price is CHF 76.70.
What is the quality score of DSFIR?
DSFIR has a Quality Score of 90/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of DSFIR (DSFIR)?
DSFIR reported trailing-twelve-month revenue of about CHF 9.0B (latest available figure, as of Jul 1, 2026).
What is the net profit margin of DSFIR?
The net profit margin of DSFIR is about -12.0%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.